Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Danish researchers' breakthrough identification of important protein

23.03.2015

Researchers from the University of Copenhagen are the first in the world to develop a secure way of measuring the important protein apo-M. This could prove relevant for research into diseases such as diabetes, arteriosclerosis and sclerosis.

For the first time, researchers from the University of Copenhagen have managed to develop a secure way of measuring the protein apo-M in our blood. The protein is interesting because it may prove important to research into diseases such as multiple sclerosis, arteriosclerosis and diabetes.

'We know that apo-M is of importance to the development of arteriosclerosis and cardiovascular diseases. Previously, we have discovered that apo-M carries a small fatty molecule, S1P, which plays a part in both diabetes and sclerosis. Whether or not apo-M is of importance, remains to be seen, however, our new and secure measuring methods open up completely new perspectives on the research being conducted in these areas', Associate Professor Christina Christoffersen from the Department of Biomedicine at the Faculty of Health and Medical Sciences explains.

Efficient and correct measuring of apo-M - or apolipoprotein M which is its name proper, has long proven a challenge to researchers across the globe. However, the Danish researchers have utilized a sandwich of commercial antibodies to identify the protein and this method has just been described in the renowned American Journal of Lipid Research.

Simply order and start

'The protein is attached to the good cholesterol, HDL, which makes measuring it difficult. It is folded like a small funnel, but expressed in popular terms, we have managed to unfold it, which makes it much easier to identify', Christina Christoffersen elaborates.

Even though it has taken several years to develop this method, it is so simple that researchers all over the world can start using it immediately.

'These antibodies are actually commercially available, so all you have to do is order them and start measuring", Christina Christoffersen concludes.

Media Contact

Christina Christoffersen
Christina.Christoffersen@regionh.dk
45-30-24-67-30

http://healthsciences.ku.dk/ 

Christina Christoffersen | EurekAlert!

More articles from Life Sciences:

nachricht Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland

nachricht Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>